# Thermo Fisher Q3 Growth Beats

> Thermo Fisher's Q3 results show 6% organic growth and raised full-year guidance.
- Title: Thermo Fisher Q3 Growth Beats · Seekingalpha | Shortify
- Summary: Thermo Fisher's Q3 results show 6% organic growth and raised full-year guidance. Thermo Fisher Scientific reported 6% organic growth, EPS and sales beats…
- Keywords: thermo fisher, q3 results, organic growth, eps, sales beats, full-year guidance, clinical research, bioproduction, electron microscopy, strategic acquisitions, operating margin, divestitures
- Source: Seekingalpha — https://seekingalpha.com/article/4956061-thermo-fisher-you-dont-need-a-microscope-to-see-the-growth-anymore
- Author: Gary Gambino
- Published: 2026-10-21T20:57:11+00:00
- Read time: 1 min
- Topics: thermo fisher, q3 results, organic growth, eps, sales beats, full-year guidance, clinical research, bioproduction, electron microscopy, strategic acquisitions, operating margin, divestitures
## Q3 Results Confirm Return To Growth
Thermo Fisher Scientific delivered strong Q3 results with 6% organic growth, EPS and sales beats, and raised full-year guidance.
## Growth Drivers
Robust demand in clinical research, bioproduction, and electron microscopy supported by recent strategic acquisitions.
## Financial Health
Operating margin reached 24.5%, aided by divestitures, acquisitions, and process improvements.
## Key takeaway

Thermo Fisher Scientific reported 6% organic growth, EPS and sales beats, and raised full-year guidance after strong clinical research and bioproduction demand.